Major histocompatibility complex class I and class II peptide-binding groove (MHC peptide-binding groove)

The Major histocompatibility complex (MHC) class I and class II peptide-binding groove is a specialized structural domain located on the surface of antigen-presenting cells and most nucleated cells. Its primary biological function is to capture and display short peptide fragments derived from both endogenous and exogenous proteins to T-cell receptors (TCRs), a process essential for the initiation of adaptive immune responses. MHC class I grooves typically bind peptides of 8-10 amino acids for presentation to CD8+ T-cells, while MHC class II grooves accommodate longer peptides of 13-25 amino acids for presentation to CD4+ T-cells. In disease states, the groove may present self-antigens leading to autoimmunity or fail to present viral/tumor antigens, allowing for immune evasion. Therapeutic targeting of the groove involves using peptide mimetics or small molecules to block the presentation of pathogenic peptides or to modulate the immune system's recognition of specific antigens. This site is also a major determinant of drug-induced hypersensitivity, where certain medications bind directly into the groove and alter the repertoire of presented peptides, leading to off-target immune activation.

Other names

MHC antigen-binding cleftHLA peptide-binding grooveMHC peptide-binding pocketAntigen-presenting grooveMHC class I and II binding site

Drugs targeting the MHC peptide-binding groove typically act by competitively inhibiting the binding of self-antigens or pathogenic peptides, or by altering the repertoire of peptides presented to T-cells. For example, Glatiramer acetate competes with myelin basic protein for binding to MHC class II molecules, thereby shifting the immune response from a pro-inflammatory to an anti-inflammatory state. Other small molecules, like Abacavir, can bind within the groove of specific HLA alleles (e.g., HLA-B*57:01), changing the shape of the cleft and causing the presentation of self-peptides that trigger hypersensitivity reactions.